Updated Guidance for Reporting Vancomycin-intermediate Staphylococcus aureus (VISA) and Vancomycin-resistant Staphylococcus aureus (VRSA)
This message is being sent to the following lists: Tribal Health Directors, Local Public Health Officers, DQA: Notifications and Updates, DQA: Assisted-Living Forum, Bureau of Communicable Disease (BCD): Information Update, Local Health Department (LHD) Nurses, Local Public Health Department Staff, Infection Preventionist, Wisconsin NHSN Users, Wisconsin NHSN Users: ASC, Wisconsin NHSN Users: LTC Facilities, and Wisconsin NHSN Users: Dialysis.
The Wisconsin Department of Health Services (DHS) has issued DPH Numbered Memo BCD 2023-03. This memo provides updated guidance for reporting VISA/VRSA in Wisconsin. In alignment with current reporting guidelines for other multidrug-resistant organisms (MDROs), VISA/VRSA shall be considered a Category II reportable condition in Wisconsin effective immediately.
Please distribute this memo widely.
All of our memos can be found on the DPH Communicable Diseases Memos webpage.
|
